Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mark FitzGerald

Showing results (221-230 of 325) with videos related to

Pageof 33
Sort By:
Lancet (London, England)|September 10, 2016
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β<sub>2</sub>-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trialEugene R Bleecker, J Mark FitzGerald, Pascal Chanez, et al.
Annals of the American Thoracic Society|May 12, 2021
Positioning As-needed Budesonide-Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2Eric D Bateman, Paul M O'Byrne, J Mark FitzGerald, et al.
The New England Journal of Medicine|May 17, 2018
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild AsthmaEric D Bateman, Helen K Reddel, Paul M O'Byrne, et al.
BMJ Open Quality|December 13, 2023
Opportunities to improve asthma and COPD prevention and care: insights from the patient journey obtained through focus groupsAneisha Collins-Fairclough, Karen Rideout, Phalgun Joshi, et al.
BMC Genomics|January 8, 2017
Enumerateblood - an R package to estimate the cellular composition of whole blood from Affymetrix Gene ST gene expression profilesCasey P Shannon, Robert Balshaw, Virginia Chen, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2017
Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary DiseaseWan C Tan, Jean Bourbeau, Shawn D Aaron, et al.
ERJ Open Research|November 14, 2019
Cholinergic synapse pathway gene polymorphisms associated with allergen-induced late asthmatic responsesAshwini Rajasekaran, Daniel He, Alice Yue, et al.
Trials|January 11, 2017
The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trialsPaul M O'Byrne, J Mark FitzGerald, Nanshan Zhong, et al.
Canadian Respiratory Journal|April 28, 2010
Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in CanadaM Diane Lougheed, Catherine Lemiere, Sharon Dell, et al.
Thorax|November 20, 2012
TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trialShawn D Aaron, Katherine L Vandemheen, François Maltais, et al.
Pageof 33

Showing results (221-230 of 325) with videos related to

Sort By:
Pageof 33
Lancet (London, England)|September 10, 2016
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β<sub>2</sub>-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trialEugene R Bleecker, J Mark FitzGerald, Pascal Chanez, et al.
Annals of the American Thoracic Society|May 12, 2021
Positioning As-needed Budesonide-Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2Eric D Bateman, Paul M O'Byrne, J Mark FitzGerald, et al.
The New England Journal of Medicine|May 17, 2018
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild AsthmaEric D Bateman, Helen K Reddel, Paul M O'Byrne, et al.
BMJ Open Quality|December 13, 2023
Opportunities to improve asthma and COPD prevention and care: insights from the patient journey obtained through focus groupsAneisha Collins-Fairclough, Karen Rideout, Phalgun Joshi, et al.
BMC Genomics|January 8, 2017
Enumerateblood - an R package to estimate the cellular composition of whole blood from Affymetrix Gene ST gene expression profilesCasey P Shannon, Robert Balshaw, Virginia Chen, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2017
Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary DiseaseWan C Tan, Jean Bourbeau, Shawn D Aaron, et al.
ERJ Open Research|November 14, 2019
Cholinergic synapse pathway gene polymorphisms associated with allergen-induced late asthmatic responsesAshwini Rajasekaran, Daniel He, Alice Yue, et al.
Trials|January 11, 2017
The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trialsPaul M O'Byrne, J Mark FitzGerald, Nanshan Zhong, et al.
Canadian Respiratory Journal|April 28, 2010
Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in CanadaM Diane Lougheed, Catherine Lemiere, Sharon Dell, et al.
Thorax|November 20, 2012
TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trialShawn D Aaron, Katherine L Vandemheen, François Maltais, et al.
Pageof 33